Publications

2024

Cytokine-centered strategies to boost cancer immunotherapy

Molecular Oncology

First author: Manzano S.

Corresponding authors: Manzano S, Caffarel MM

A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer

Breast Cancer Research

First author: López-Velazco JI et al.

Corresponding authors: Caffarel MM, Urruticoechea A

Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER(+) breast cancer

Science Translational Medicine

First author: Bacci M et al.

Corresponding authors: Morandi A

Preventing alpelisib-related hyperglycaemia in HR+/HER2-/ PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

eClinicalMedicine

First author: Llombart-Cussac A et al.

Corresponding authors: Llombart-Cussac A

Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial

Nature Medicine

First author: Hiensch AE et al.

Corresponding authors: May AM

Use of Gain-of-Function Screening to Identify miRNAs Involved in Paclitaxel Resistance in Triple-Negative Breast Cancer

International Journal of Molecular Science

First author: Nemours S, et al.

Corresponding authors: Lawrie CH

Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study

Breast

First author: Cortés A et al.

Corresponding authors: Llombart-Cussac A

Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis

Science Advances

First author: Bakhshandeh S and Heras U et al.

Corresponding authors: Cipitria A

2023

Cytokine-centered strategies to boost cancer immunotherapy

Molecular Oncology

First author: Manzano S.

Corresponding authors: Manzano S, Caffarel MM

A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer

Breast Cancer Research

First author: López-Velazco JI et al.

Corresponding authors: Caffarel MM, Urruticoechea A

Acetyl-CoA carboxylase 1 controls a lipid droplet-peroxisome axis and is a vulnerability of endocrine-resistant ER(+) breast cancer

Science Translational Medicine

First author: Bacci M et al.

Corresponding authors: Morandi A

Preventing alpelisib-related hyperglycaemia in HR+/HER2-/ PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial

eClinicalMedicine

First author: Llombart-Cussac A et al.

Corresponding authors: Llombart-Cussac A

Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial

Nature Medicine

First author: Hiensch AE et al.

Corresponding authors: May AM

Use of Gain-of-Function Screening to Identify miRNAs Involved in Paclitaxel Resistance in Triple-Negative Breast Cancer

International Journal of Molecular Science

First author: Nemours S, et al.

Corresponding authors: Lawrie CH

Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study

Breast

First author: Cortés A et al.

Corresponding authors: Llombart-Cussac A

Dormancy-inducing 3D engineered matrix uncovers mechanosensitive and drug-protective FHL2-p21 signaling axis

Science Advances

First author: Bakhshandeh S and Heras U et al.

Corresponding authors: Cipitria A